《大行报告》花旗引述友邦(01299.HK)管理层指第二季内地业务面临挑战
花旗发表报告表示,引述友邦(01299.HK)管理层透露,今年第二季内地业务较首季更具挑战,主因去年比较基数高、市场对危疾产品的早期需求和新产品教育过程等因素。不过管理层称,注意到与新危疾产品相关的活动有所增加,集团仍以每年在内地新增一至两个省级牌照为目标,并会通过提前招聘新的分行管理人员作准备。
该行补充,香港业务而言,虽然边境关闭可能会减少不活跃的经纪人数,但友邦协助该等经纪转向拓展本地市场。管理层亦指出,最近东盟市场封锁措施带来问题,但在电子化下,代理有更好的准备。该行予友邦「买入」评级,目标价为116元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.